These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer. Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870 [TBL] [Abstract][Full Text] [Related]
11. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer. Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer. Masago K; Fujita S; Hatachi Y; Fukuhara A; Sakuma K; Ichikawa M; Kim YH; Mio T; Mishima M Cancer Sci; 2008 Nov; 99(11):2295-301. PubMed ID: 18811692 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Luppi F; Longo AM; de Boer WI; Rabe KF; Hiemstra PS Lung Cancer; 2007 Apr; 56(1):25-33. PubMed ID: 17175059 [TBL] [Abstract][Full Text] [Related]
14. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer. Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572 [TBL] [Abstract][Full Text] [Related]
15. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer. Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074 [TBL] [Abstract][Full Text] [Related]
16. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045 [TBL] [Abstract][Full Text] [Related]
17. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. Eberhard DA; Giaccone G; Johnson BE; J Clin Oncol; 2008 Feb; 26(6):983-94. PubMed ID: 18281673 [TBL] [Abstract][Full Text] [Related]
19. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer. Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868 [TBL] [Abstract][Full Text] [Related]
20. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine. García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]